Showing results (921-930 of 2,715) with videos related to
Sort By:
Pageof 272
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 23, 2009
Unusual cause of wide complex tachycardia during coronary angiographyMayank M Kansal, Mladen I VidovichCardiovascular Revascularization Medicine : Including Molecular Interventions|January 23, 2009
Superselective embolization of renal hemorrhage occurring after percutaneous coronary interventionLuca Favero, Salvatore Saccà, Carlo Cernetti, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|February 13, 2007
Drug-eluting stent implantation in ST-elevation acute myocardial infarction: 'real world' 30-day and mid-term resultsGian M Novaro, Aparna Cherla, Kenneth R Fromkin, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|February 13, 2007
Preprocedure hyperglycemia is more strongly associated with restenosis in diabetic patients after percutaneous coronary intervention than is hemoglobin A1CJoseph Lindsay, Arvind K Sharma, Daniel Canos, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|February 13, 2007
Low-energy gamma-emitting stents inhibit intimal hyperplasia with minimal "edge effects" in a pig coronary artery modelMichael J B Kutryk, Michael A Kuliszewski, Ronen Jaffe, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|February 13, 2007
Cell therapy in myocardial infarctionSara D Collins, Richard Baffour, Ron WaksmanCardiovascular Revascularization Medicine : Including Molecular Interventions|July 15, 2009
Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary interventionCédric Delhaye, Arnaud Sudre, Gilles Lemesle, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 15, 2009
Head-to-head comparison of bivalirudin versus heparin without glycoprotein IIb/IIIa inhibitors in patients with acute myocardial infarction undergoing primary angioplastyLaurent Bonello, Axel de Labriolle, Probal Roy, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 31, 2009
Drug-eluting or bare-metal stents in subjects over 75 years of age: what is the best therapeutic strategy? Data from 460 consecutive patients with 1-year outcomeHorma Ouldzein, Jérome Roncalli, Walid Zouaoui, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 31, 2009
Comparison of percutaneous coronary intervention in native coronary arteries vs. bypass grafts in patients with prior coronary artery bypass graft surgeryIndu Varghese, Jepsin Samuel, Subhash Banerjee, et al.Pageof 272